Vir Biotechnology CEO George Scangos' 2019 pay jumps 404% to $3.9M
Vir Biotechnology reports 2019 executive compensation
By ExecPay News
Published: April 6, 2020
Vir Biotechnology reported fiscal year 2019 executive compensation information on April 6, 2020.
In 2019, three executives at Vir Biotechnology received on average a compensation package of $2.7M, a 84% increase compared to previous year.
Average pay of disclosed executives at Vir Biotechnology
George Scangos, Chief Executive Officer, received $3.9M in total, which increased by 404% compared to 2018. 80% of Scangos' compensation, or $3.2M, was in option awards. Scangos also received $260K in non-equity incentive plan, $515K in salary, as well as $11K in other compensation.
Howard Horn, Chief Financial Officer, received a compensation package of $2.2M. 73% of the compensation package, or $1.6M, was in option awards.
Herbert Skip Virgin, Chief Scientific Officer, earned $2M in 2019, a 9% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 6, 2020.